Clinical Trial

Optimization of STAR

Study acronym: STAR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is optimize the STAR (SympTom mAnagement self-caRe) intervention to support patients with HF in staying healthy, and particularly in self-monitoring and managing symptoms. The STAR intervention includes promising components aiming at improving patient outcomes in terms of interference of bothersome symptoms, self-care, quality of life (QoL) and healthcare utilization. In this study, the intervention components are tested in an optimization trial in 320 patients with HF from 8 HF clinics in the Netherlands. This study will result in an optimized STAR intervention, composed of the best components, that is effective, scalable, and efficient to improve patient outcomes and can be used in HF clinics.
Trial Details
NCT Number NCT07065578
Lead Sponsor UMC Utrecht
Collaborators: Dutch Heart Foundation
Conditions Heart Failure NYHA Class II, Heart Failure NYHA Class III
Enrollment 320 participants
Start Date 2025-07
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-15